On May 28, Jiudian Pharmaceutical It was announced that the Company had held the 2023 Annual General Meeting of Shareholders on May 15, 2024, and reviewed and passed the proposal on adjusting matters related to joint investment with professional investment institutions and related transactions. The Company signed relevant transfer agreement with Yunnan International Trust Co., Ltd. to transfer 20% of the property shares of Shenzhen Hongdian Shengshi Pharmaceutical Investment Partnership (Limited Partnership) held by Yunnan Trust (corresponding subscribed or paid in capital contribution is 40 million yuan), and the total transfer price is 53.124 million yuan. Recently, the company received the notice of the partnership to complete the industrial and commercial registration of changes, and the proportion of Jiudian Pharmaceutical's contribution to it has changed from 5.00% to 25.00%.
When the stock market recovers, open an account first! Intelligent fixed investment, condition sheet, individual stock radar... for you>>
Massive information, accurate interpretation, all in Sina Finance APP
